[1]
|
A. Jemal, R. Siegel, J. Xu, et al., “Cancer Statistics,” CA: A Cancer Journal for Clinicians, Vol. 60, No. 5, 2010, pp. 277-300. doi:10.3322/caac.20073
|
[2]
|
J. M. Fitzpatrick, “Management of Localized Prostate Cancer in Senior Adults: The Crucial Role of Comorbidity,” BJU International, Vol. 101, Suppl.2, 2008, pp. 16-22. doi:10.1111/j.1464-410X.2007.07487.x
|
[3]
|
D. Ilic, D. O’Connor, S. Green, et al., “Screening for Prostate Cancer: An Updated Cochrane Systematic Review,” BJU International, Vol. 107, No. 6, 2011, pp. 882-891.doi:10.1111/j.1464-410X.2010.10032.x
|
[4]
|
US Preventive Services Task Force, “Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement,” Annals of Internal Medicine, Vol. 122, No. 1, 2008, pp. 185-191. doi:10.1542/peds.2007-2210
|
[5]
|
J. L. Mohler, R. R. Bahnson, B. Boston, et al., “NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer,” Journal of the National Comprehensive Cancer Network, Vol. 10, No. 9, 2010, pp. 162-200.
|
[6]
|
M. S. Cookson, G. Aus, A. L. Burnett, et al., “Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes,” The Journal of Urology, Vol. 177, No. 2, 2007, pp. 540-545. doi:10.1016/j.juro.2006.10.097
|
[7]
|
M. Roach, G. Hanks, H. Thames, et al., “Defining Biochemical Failure Following Radiotherapy with or without Hormonal Therapy in Men with Clinically Localized Prostate Cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference,” International Journal of Radiation Oncology, Biology, Physics, Vol. 65, No. 4, 2006, pp. 965-974. doi:10.1016/j.ijrobp.2006.04.029
|
[8]
|
N. B. Delongchamps, C. Y. Wang, V. Chandan, et al., “Pathological Characteristics of Prostate Cancer in Elderly Men,” The Journal of Urology, Vol. 182, No. 3, 2009, pp. 927-930. doi:10.1016/j.juro.2009.05.018
|
[9]
|
J. C. Sung, J. N. Kabalin and M. K. Terris, “Prostate Cancer Detection, Characterization, and Clinical Outcomes in Men Aged 70 Years and Older Referred for Transrectal Ultrasound and Prostate Biopsies,” Urology, Vol. 56, No. 2, 2000, pp. 295-301.doi:10.1016/S0090-4295(00)00611-7
|
[10]
|
K. Lin, R. Lipsitz, T. Miller, et al., “Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the US Preventive Services Task Force,” Annals of Internal Medicine, Vol. 149, No. 63, 2008, pp. 192-199.
|
[11]
|
P. C. Albertsen, J. A. Hanley and J. Fine, “20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer,” The Journal of the American Medical, Vol. 293, No. 17, 2005, pp. 2095-2101.doi:10.1001/jama.293.17.2095
|
[12]
|
C. B. Begg, E. R. Riedel, P. B. Bach,et al., “Variations in Morbidity after Radical Prostatectomy,” The New England Journal of Medicine, Vol. 346, 2002, pp. 1138-1144. doi:10.1056/NEJMsa011788
|
[13]
|
A. Bill-Axelson, L. Holmberg, F. Filen, et al., “Radical Prostatectomy versus Watchful Waiting in Localized Prostate Cancer: The Scandinavian Prostate Cancer Group-4 Randomized Trial,” Journal of the National Cancer Institute, Vol. 100, No. 16, 2008, pp. 1144-1154. doi:10.1093/jnci/djn255
|
[14]
|
T. Bubolz, J. H. Wasson, L.-Y. Grace, et al., “Treatments for Prostate Cancer in Older Men: 1984-1997,” Urology, Vol. 58, No. 6, 2001, pp. 977-982. doi:10.1016/S0090-4295(01)01434-0
|
[15]
|
P. A. Kupelian, L. Potters, D. Khuntia, et al., “Radical Prostatectomy, External Beam Radiotherapy < 72 Gy, External Beam Radiotherapy > or =72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer,” International Journal of Radiation Oncology, Biology, Physics, Vol. 58, No. 1, 2004, pp. 25-33. doi:10.1016/S0360-3016(03)00784-3
|
[16]
|
S. M. Alibhai, M. Leach, G. A. Tomlinson, et al., “Is There an Optimal Comorbidity Index for Prostate Cancer?” Cancer, Vol. 112, No. 5, 2008, pp. 1043-1050. doi:10.1002/cncr.23269
|
[17]
|
K. L. Schwartz, S. M. Alibhai, G. Tomlinson, et al., “Continued Undertreatment of Older Men with Localized Prostate Cancer,” Urology, Vol. 62, No. 5, 2003, pp. 860-865. doi:10.1016/S0090-4295(03)00690-3
|